Related references
Note: Only part of the references are listed.Oncogene addiction: pathways of therapeutic response, resistance, and road maps toward a cure
Raymond Pagliarini et al.
EMBO REPORTS (2015)
Tyrosine Kinase Inhibition in Leukemia Induces an Altered Metabolic State Sensitive to Mitochondrial Perturbations
Francesca Alvarez-Calderon et al.
CLINICAL CANCER RESEARCH (2015)
Valproic acid enhances fludarabine-induced apoptosis mediated by ROS and involving decreased AKT and ATM activation in B-cell-lymphoid neoplastic cells
Ju-Yoon Yoon et al.
APOPTOSIS (2014)
Mitochondria are required for ATM activation by extranuclear oxidative stress in cultured human hepatoblastoma cell line Hep G2 cells
Akinori Morita et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Targeting antioxidants for cancer therapy
Andrea Glasauer et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Will FLT3 inhibitors fulfill their promise in acute myeloid leukemia?
Keith W. Pratz et al.
CURRENT OPINION IN HEMATOLOGY (2014)
New strategies for relapsed acute myeloid leukemia: fertile ground for translational research
Shira N. Dinner et al.
CURRENT OPINION IN HEMATOLOGY (2014)
Quizartinib for the treatment of FLT3/ITD acute myeloid leukemia
Mark Levis
FUTURE ONCOLOGY (2014)
The cytotoxicity of the anticancer drug elesclomol is due to oxidative stress indirectly mediated through its complex with Cu(II)
Brian B. Hasinoff et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2014)
Synergistic Anti-Cancer Effect of Phenformin and Oxamate
W. Keith Miskimins et al.
PLOS ONE (2014)
Metabolic effect of TAp63α: enhanced glycolysis and pentose phosphate pathway, resulting in increased antioxidant defense
Angelo D'Alessandro et al.
ONCOTARGET (2014)
Glutathione and mitochondria
Vicent Ribas et al.
FRONTIERS IN PHARMACOLOGY (2014)
Pathogenesis of ataxia-telangiectasia: the next generation of ATM functions
Mark Ambrose et al.
BLOOD (2013)
Targeting Aberrant Glutathione Metabolism to Eradicate Human Acute Myelogenous Leukemia Cells
Shanshan Pei et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Large-scale gene function analysis with the PANTHER classification system
Huaiyu Mi et al.
NATURE PROTOCOLS (2013)
Modulation of oxidative stress as an anticancer strategy
Chiara Gorrini et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
The ATM protein kinase: regulating the cellular response to genotoxic stress, and more
Yosef Shiloh et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
A ROS rheostat for cell fate regulation
Maria Maryanovich et al.
TRENDS IN CELL BIOLOGY (2013)
Mitochondrial dysfunction in ataxia-telangiectasia
Yasmine A. Valentin-Vega et al.
BLOOD (2012)
The oncology drug elesclomol selectively transports copper to the mitochondria to induce oxidative stress in cancer cells
Masazumi Nagai et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Targeting the FMS-like tyrosine kinase 3 in acute myeloid leukemia
R. Swords et al.
LEUKEMIA (2012)
Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia
Catherine C. Smith et al.
NATURE (2012)
Mitochondrial Electron Transport Is the Cellular Target of the Oncology Drug Elesclomol
Ronald K. Blackman et al.
PLOS ONE (2012)
Metabolic reprogramming in cancer: Unraveling the role of glutamine in tumorigenesis
Dania Daye et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2012)
Inhibition of Mitochondrial Translation as a Therapeutic Strategy for Human Acute Myeloid Leukemia
Marko Skrtic et al.
CANCER CELL (2011)
ATM activates the pentose phosphate pathway promoting anti-oxidant defence and DNA repair
Claudia Cosentino et al.
EMBO JOURNAL (2011)
Oncogene addiction as a foundational rationale for targeted anti-cancer therapy: promises and perils
Davide Torti et al.
EMBO MOLECULAR MEDICINE (2011)
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
Gina M. De Nicola et al.
NATURE (2011)
Mitochondrial dysfunction in some oxidative stress-related genetic diseases: Ataxia-Telangiectasia, Down Syndrome, Fanconi Anaemia and Werner Syndrome
Federico V. Pallardo et al.
BIOGERONTOLOGY (2010)
Wnt/Ca2+/NFAT Signaling Maintains Survival of Ph+ Leukemia Cells upon Inhibition of Bcr-Abl
Mark A. Gregory et al.
CANCER CELL (2010)
The ATM Inhibitor KU-55933 Suppresses Cell Proliferation and Induces Apoptosis by Blocking Akt In Cancer Cells with Overactivated Akt
Yan Li et al.
MOLECULAR CANCER THERAPEUTICS (2010)
ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS
Angela Alexander et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity
Frank Weinberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Glutamine addiction: a new therapeutic target in cancer
David R. Wise et al.
TRENDS IN BIOCHEMICAL SCIENCES (2010)
Redox-Directed Cancer Therapeutics: Molecular Mechanisms and Opportunities
Georg T. Wondrak
ANTIOXIDANTS & REDOX SIGNALING (2009)
Metabolic characteristics of imatinib resistance in chronic myeloid leukaemia cells
Jelena Klawitter et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Dunyaporn Trachootham et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
A targetable fluorescent probe for imaging hydrogen peroxide in the mitochondria of living cells
Bryan C. Dickinson et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Elesclomol induces cancer cell apoptosis through oxidative stress
Jessica R. Kirshner et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Deregulation of signaling pathways in acute myeloid leukemia
Claudia Scholl et al.
SEMINARS IN ONCOLOGY (2008)
Antitumor activity of sorafenib in FLT3-driven leukemic cells
D. Auclair et al.
LEUKEMIA (2007)
FLT3 mutations in childhood acute lymphoblastic leukemia
SA Armstrong et al.
BLOOD (2004)
Imatinib (STI571)-mediated changes in glucose metabolism in human leukemia BCR-ABL-positive cells
S Gottschalk et al.
CLINICAL CANCER RESEARCH (2004)
The role of FLT3 in haematopoietic malignancies
DL Stirewalt et al.
NATURE REVIEWS CANCER (2003)
Is there a cloud in the silver lining for imatinib?
SC Paterson et al.
BRITISH JOURNAL OF CANCER (2003)
Share Paper
